Clin Mol Hepatol > Volume 30(3); 2024 > Article
Clinical and Molecular Hepatology 2024;30(3): 580-581.
doi: https://doi.org/10.3350/cmh.2024.0301
Functional cure of chronic hepatitis B encounters resmetirom
Nai-Bin Yang1,2, Wai-Kay Seto3,4,5, Ming-Hua Zheng6,7
1Department of Hepatology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China
2Ningbo Key Laboratory of Translational Medicine Research on Gastroenterology and Hepatology, Ningbo, Zhejiang, China
3Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China
4Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangzhou, China
5State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China
6MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
7Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, Zhejiang, China
Correspondence :  Ming-Hua Zheng ,
Tel: +86-577-55579611, Fax: +86-577-55578522, Email: zhengmh@wmu.edu.cn
Received: April 25, 2024  Revised: April 29, 2024   Accepted: April 29, 2024
KeyWords: Resmetirom; Metabolic dysfunction-associated steatohepatitis; Hepatitis B, chronic; Functional cure

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1213
TOTAL : 1926890
Close layer